Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Hims & Hers Health, Inc. publishes a filing, an earnings call transcript or a press release.
Get HIMS alertsYemi Okupe is recorded as CFO at Hims & Hers Health, Inc. (HIMS). Yemi Okupe has spoken on 20 earnings calls and 1 other investor event across 1 company, most recently for Hims & Hers Health, Inc. on November 9, 2026. Hims & Hers Health, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Hims & Hers Health, Inc. includes Andrew Dudum (CEO and Board Member), Mr. Dudum (CEO), Irene A. Becklund (CFO) and 7 others.
“In the third quarter, we continue to apply learnings to make a deliberate set of decisions that we are confident will position hims and hers for durable multi-year growth.”
“Today, I'll walk through progress made in the second quarter across our key growth levers, as well as investments we are making to bring a better health experience to millions of consumers globally and capture the immense opportunity in front of us.”
“I think what I'd focus on is the fact that there is an amazing opportunity in front of us to transform the healthcare space. I think more and more consumers are just taking control of their own health.”
“In March, we made a deliberate strategic pivot within our weight loss specialty, one that we knew would create near-term financial noise to unlock immense potential for the platform to accelerate at scale.”
“I'll start by providing an overview of our fourth quarter financial performance before diving further into our outlook for 2026.”
Drug Manufacturers - Specialty & Generic · Healthcare
CFO